Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Patent
1996-11-12
1997-12-23
Witz, Jean C.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
4352525, 504117, A01N 6300, A01N 6302, C12N 120
Patent
active
057004625
ABSTRACT:
A novel strain of Bacillus cereus, designated MS1-9, has been isolated from the environment. The strain MS1-9, ATCC 55812, is one of a number of B. cereus strains which are useful as biocontrol agents to combat fungal damping off disease in field crop plants, and strain MS1-9 has exhibited good performance under high disease pressure among a large number of natural isolates in fostering the emergence and growth of alfalfa plants under normal field conditions in the upper midwestern U.S.
REFERENCES:
patent: 4877738 (1989-10-01), Handelsman et al.
patent: 5543301 (1996-08-01), Handelsman et al.
patent: 5552138 (1996-09-01), Handelsman et al.
Goodman Robert M.
Handelsman Jo
Jacobson Lynn M.
Johnson David W.
Smith Kevin P.
Hanley Susan
Wisconsin Alumni Research Foundation
Witz Jean C.
LandOfFree
Bacillus cereus strain MS1-9, ATCC 55812 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacillus cereus strain MS1-9, ATCC 55812, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacillus cereus strain MS1-9, ATCC 55812 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1800408